South Africa

BMI View: Litha Healthcare Group's strategy of rapid acquisitions to diversify its product sales in vaccines, pharmaceuticals and medical devices is well timed to take advantage of... 2011-12-14

BMI View: Post-apartheid South Africa has underinvested in research and development (R&D), which has had a knock-on effect on the country's ability to compete in the field of clinical... 2011-12-01

BMI View: Adcock Ingram's strategy to expand in Sub-Saharan Africa is going to be a big generator of wealth for the company's future, but it has been slow to expand in the region compared... 2011-10-21

BMI View: South Africa's timescale for enacting its National Health Insurance (NHI) scheme is practical and achievable, as are their goals of improving governance, administration and... 2011-08-15

BMI View: South Africa already has a dynamic and competitive local pharmaceutical industry which meets the majority of the country's needs for antiretroviral (ARV) drugs. The African... 2011-07-25

BMI View: Although South Africa's anti-HIV/AIDS strategy appears to be in trouble - as the prevalence rate is far higher than expected - it is possible that part of this growth could... 2011-07-01

BMI View: Most South African drugmakers have already made an effort to attain a high black economic empowerment (BEE) rating and have welcomed alterations to the drug tender regulations.... 2011-06-15